Market Access News | pharmaphorum

News

UK postcode lottery ends for 'life-changing' cystinosis drug

Patients in England with rare disease cystinosis will soon be able to access a drug that has been available in other UK nations for up to three years

News

Are we about to see a return for the pharma mega-merger?

There are rumours that the first pharma 'mega-merger' for several years – between AstraZeneca and Bristol Myers Squibb – is under discussion.

News

Datroway joins Trodelvy for frontline TNBC in the EU

AstraZeneca and Daiichi Sankyo's Datroway enters the first-line triple-negative breast cancer market in the EU, taking on Gilead's Trodelvy.

News

Adcomm backs Replimune melanoma drug, despite data concern

Replimune's RP1 immunotherapy for melanoma clears advisory committee vote by 10 to three, despite FDA concerns about the design of the IGNYTE study.

News

Cytokinetics' cardiomyopathy drug cleared for NHS use

Cytokinetics gets simultaneous MHRA and NICE approvals for hypertrophic cardiomyopathy (HCM) therapy Myqorzo.

News

Lawmakers seek answers from RFK on Gardasil shot settlement

Four Democratic senators are investigating whether the family of HHS Secretary RFK Jr is profiting from what they assert are "bogus" vaccine lawsuits.

UK postcode lottery ends for 'life-changing' cystinosis drug

Are we about to see a return for the pharma mega-merger?

Datroway joins Trodelvy for frontline TNBC in the EU

Adcomm backs Replimune melanoma drug, despite data concern

Cytokinetics' cardiomyopathy drug cleared for NHS use

Lawmakers seek answers from RFK on Gardasil shot settlement

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks